NO943101L - 2,6-metano-2H-kinolizinderivat som 5-HT3-reseptorantagonist - Google Patents
2,6-metano-2H-kinolizinderivat som 5-HT3-reseptorantagonistInfo
- Publication number
- NO943101L NO943101L NO943101A NO943101A NO943101L NO 943101 L NO943101 L NO 943101L NO 943101 A NO943101 A NO 943101A NO 943101 A NO943101 A NO 943101A NO 943101 L NO943101 L NO 943101L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- methano
- receptor antagonist
- quinolizine derivative
- hallucinatory
- Prior art date
Links
- 229940113081 5 Hydroxytryptamine 3 receptor antagonist Drugs 0.000 title 1
- FSVCFXBTJXBMOS-UHFFFAOYSA-N C1=CC(N2C=C3)=CC3CC2=C1 Chemical class C1=CC(N2C=C3)=CC3CC2=C1 FSVCFXBTJXBMOS-UHFFFAOYSA-N 0.000 title 1
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 title 1
- 229940127239 5 Hydroxytryptamine receptor antagonist Drugs 0.000 abstract 1
- MKFUPDDTJDQJGS-UHFFFAOYSA-N C1C(N2CC3O)CC3CC2CC1OC(=O)C1=C(OC(C)(C)C2)C2=CC(Cl)=C1 Chemical compound C1C(N2CC3O)CC3CC2CC1OC(=O)C1=C(OC(C)(C)C2)C2=CC(Cl)=C1 MKFUPDDTJDQJGS-UHFFFAOYSA-N 0.000 abstract 1
- 206010013654 Drug abuse Diseases 0.000 abstract 1
- 206010026749 Mania Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000003420 antiserotonin agent Substances 0.000 abstract 1
- 230000000973 chemotherapeutic effect Effects 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 230000003400 hallucinatory effect Effects 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000001107 psychogenic effect Effects 0.000 abstract 1
- 230000003439 radiotherapeutic effect Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92400474 | 1992-02-24 | ||
| PCT/US1993/000880 WO1993017019A1 (en) | 1992-02-24 | 1993-02-03 | 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO943101D0 NO943101D0 (no) | 1994-08-23 |
| NO943101L true NO943101L (no) | 1994-08-23 |
Family
ID=8211614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943101A NO943101L (no) | 1992-02-24 | 1994-08-23 | 2,6-metano-2H-kinolizinderivat som 5-HT3-reseptorantagonist |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0628043A1 (enExample) |
| JP (1) | JPH07504192A (enExample) |
| KR (1) | KR100287933B1 (enExample) |
| AU (1) | AU675060B2 (enExample) |
| CA (1) | CA2130563C (enExample) |
| FI (1) | FI105917B (enExample) |
| HU (1) | HU216831B (enExample) |
| IL (1) | IL104821A (enExample) |
| MX (1) | MX9300948A (enExample) |
| NO (1) | NO943101L (enExample) |
| NZ (1) | NZ249346A (enExample) |
| TW (1) | TW226374B (enExample) |
| WO (1) | WO1993017019A1 (enExample) |
| ZA (1) | ZA931146B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002537255A (ja) | 1999-02-18 | 2002-11-05 | ノバルティス アクチエンゲゼルシャフト | リウマチ性炎症性プロセスに対する５−ｈｔ３レセプターアンタゴニストの全身的使用 |
| US8524731B2 (en) | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
| US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| MX2007010833A (es) | 2005-03-07 | 2009-02-17 | Univ Chicago | Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0329932B1 (en) * | 1988-02-23 | 1995-10-18 | Merrell Pharmaceuticals Inc. | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments |
| EP0517984A1 (en) * | 1991-06-11 | 1992-12-16 | Merrell Dow Pharmaceuticals Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
-
1993
- 1993-02-03 KR KR1019940702945A patent/KR100287933B1/ko not_active Expired - Lifetime
- 1993-02-03 JP JP5514868A patent/JPH07504192A/ja active Pending
- 1993-02-03 WO PCT/US1993/000880 patent/WO1993017019A1/en not_active Ceased
- 1993-02-03 EP EP93904797A patent/EP0628043A1/en not_active Withdrawn
- 1993-02-03 AU AU36034/93A patent/AU675060B2/en not_active Expired
- 1993-02-03 HU HU9402436A patent/HU216831B/hu unknown
- 1993-02-03 NZ NZ249346A patent/NZ249346A/en not_active IP Right Cessation
- 1993-02-03 CA CA002130563A patent/CA2130563C/en not_active Expired - Lifetime
- 1993-02-18 ZA ZA931146A patent/ZA931146B/xx unknown
- 1993-02-19 TW TW082101189A patent/TW226374B/zh not_active IP Right Cessation
- 1993-02-22 IL IL10482193A patent/IL104821A/xx not_active IP Right Cessation
- 1993-02-22 MX MX9300948A patent/MX9300948A/es unknown
-
1994
- 1994-08-23 NO NO943101A patent/NO943101L/no unknown
- 1994-08-23 FI FI943872A patent/FI105917B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MX9300948A (es) | 1993-08-01 |
| CA2130563C (en) | 1997-11-11 |
| HU216831B (hu) | 1999-09-28 |
| ZA931146B (en) | 1993-09-14 |
| NO943101D0 (no) | 1994-08-23 |
| FI105917B (fi) | 2000-10-31 |
| HUT68249A (en) | 1995-06-28 |
| AU675060B2 (en) | 1997-01-23 |
| FI943872L (fi) | 1994-08-23 |
| KR100287933B1 (ko) | 2001-05-02 |
| EP0628043A1 (en) | 1994-12-14 |
| JPH07504192A (ja) | 1995-05-11 |
| NZ249346A (en) | 1995-10-26 |
| AU3603493A (en) | 1993-09-13 |
| CA2130563A1 (en) | 1993-09-02 |
| IL104821A0 (en) | 1993-06-10 |
| TW226374B (enExample) | 1994-07-11 |
| WO1993017019A1 (en) | 1993-09-02 |
| KR950700297A (ko) | 1995-01-16 |
| HU9402436D0 (en) | 1994-10-28 |
| IL104821A (en) | 1997-01-10 |
| FI943872A0 (fi) | 1994-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005202257C1 (en) | Azacyclic compounds for use in the treatment of serotonin related diseases | |
| TW200505901A (en) | Muscarinic agonists | |
| DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
| BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
| NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
| WO2000064441A3 (en) | Compound for use as a medicament for treatment of disorders involving bronchocontraction | |
| MA28021A1 (fr) | Dérivés de benzimidazolone à activité agoniste des récepteurs 5-HT4 | |
| RU93058531A (ru) | Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ лечения | |
| NO20044501L (no) | [1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler | |
| WO2004105682A3 (en) | Carbostyril derivatives and mood stabilizers for treating mood disorders | |
| DK0765320T3 (da) | Benzimidazolonderivater med central dopaminerg aktivitet | |
| DE69818678D1 (de) | (+)-norcisapride verwendbar bei 5-ht3 und 5-ht4 bedingten krankheiten | |
| NO20055531L (no) | Preparat for forbedret kognisjon og hukommelse | |
| FI970469A0 (fi) | Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus | |
| EA200400302A1 (ru) | Способ лечения первичной бессонницы | |
| BR9911302A (pt) | Métodos para tratar bulimia, para tratar distúrbios mediados por atividade vagal, para tratar sìndrome de intestino irritável, para tratar apnéia ou distúrbios de apnéia, para prevenir ou controlar bulimia, distúrbios mediados por atividade vagal, sìndrome de intestino irritável, bradicardia ou bradiarritmia, asma, incontinência urinária, e, apnéia ou distúrbios da apnéia em um paciente | |
| WO2000076500A3 (en) | Compound for use as a medicament for treatment of disorders involving bronchocontraction | |
| MXPA02006146A (es) | Uso de metabolitos bioactivos de gepirona para el tratamiento de desordenes psicologicos. | |
| NO20005223L (no) | Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen | |
| NO984651L (no) | Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet | |
| CA2130563A1 (en) | 2,6-Methano-2H-Quinolizin Derivative as 5-HT3-Receptor Antagonist | |
| EP1632235A3 (en) | Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders | |
| Glasper et al. | Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report | |
| ATE271867T1 (de) | Behandlung der harninkontinenz und zusammenstellung dafür | |
| NO951865L (no) | Quinuclidin-derivat som substans-P antagonist |